Wednesday, September 2, 2026

2:15 PM - 3:45 PM

---

Details

Organised by the FIP Technology Advisory Group in collaboration with the FIP Early Career Pharmaceutical Group and the FIP Humanitarian Resilience Advisory Group Chair(s) Dr Joël Fossouo Tagne, Member, the FIP Technology Advisory Group, Australia & Prof. Giovanni Pauletti, Vice President, International Pharmaceutical Federation, USA Introduction: Medicine donation sits at the intersection of social goodwill, complex humanitarian logistics and supply chains. While it can reduce waste and expand access, uncoordinated donation practices carry significant risks related to quality, efficiency, and traceability, including inappropriate supply and potential for antimicrobial resistance (AMR) risks. This session brings a national-to-global perspective on how digital innovation and governance frameworks can strengthen responsible redistribution cross the medicines lifecycle. At the national level, GIVMED showcases a structured model enabling pharmacy-based donations for vulnerable populations in Greece through digital matching and traceability tools. At the global level, WHO manages large-scale procurement and emergency supply systems such as the Interagency Emergency Health Kit, built on strict standards of safety and coordination to support needs-based distribution and quality assurance. Together, these perspectives highlight how pharmacists and humanitarian actors can build ethical, technology-enabled pathways that reduce waste while ensuring equitable and safe access while strengthening environmental stewardship and “One Health” principles. The session will provide practical examples of how digital tools (e.g., barcode-based tracking, expiry verification, and audit trails) improve traceability, quality assurance, and AMR risk mitigation, particularly in humanitarian and LMIC contexts. Programme: Learning objectives: 1. Describe how responsible medicine-donation practices and digital tools reduce waste while improving safe, equitable, and needs-based access to essential medicines across settings. 2. Explain how AI, multilingual systems, and digital tracking technologies can strengthen transparency, quality assurance, and coordination in both community-level and large-scale humanitarian donation pathways. 3. Identify opportunities for pharmacists, NGOs, and global agencies to collaborate on governance, technology, and partnerships that enable safe, sustainable, and equitable medicine-donation ecosystems. Take home messages: Digital innovation can support safe, transparent, and needs-aligned medicine redistribution when grounded in established humanitarian donation principles and responsible stewardship across the medicine’s lifecycle. Multilingual platforms and tracking tools can improve visibility and coordination across national and global systems while strengthening traceability and quality assurance. Effective collaboration between pharmacists, NGOs, and international agencies and industry stakeholders strengthens equity, reduces waste, and safeguards the quality of donated medicines including through improved AMR risk mitigation in humanitarian contexts. FIP Development Goals: To learn more about these FIP Development Goals, click on the links below. FIP Development Goal 18: Access to Medicines, Devices & Services FIP Development Goal 20: Digital Health FIP Development Goal 21: Sustainability in Pharmacy

---

Chairs & speakers